Neurosurgical Review

, Volume 35, Issue 4, pp 485–495 | Cite as

Management of non-traumatic intraventricular hemorrhage

Review

Abstract

Intraventricular hemorrhage (IVH) is defined as the eruption of blood in the cerebral ventricular system and is mostly secondary to spontaneous intracerebral hemorrhage and aneurysmal and arteriovenous malformation rupture. IVH is a proven risk factor of increased mortality and poor functional outcome. Its seriousness is correlated not only with the amount of blood but also with the involvement of the third and fourth ventricles. There are four mechanisms that explain the pathophysiology of this event: acute obstructive hydrocephalus, the mass effect exerted by the blood clot, the toxicity of blood-breaking products on the adjacent brain parenchyma, and, lastly, the development of a chronic hydrocephalus. It is thus obvious that the clearance of blood from the ventricles should be a therapeutic goal. In cases of acute hydrocephalus, external ventricular drainage is a mandatory step, but proven often insufficient. The concomitant use of intraventricular fibrinolytics such as recombinant tissue plasminogen activator or urokinase seems to be beneficial at least in the context of spontaneous intracerebral hemorrhage, in which their use is now accepted but not yet validated by a randomized trial. Given the potential neurotoxicity of these agents, further research is needed in order to identify the best treatment for intraventricular fibrinolysis (IVF). The endoscopic retrieval of intraventricular blood was also described recently and seems to be as efficient as IVF, but its use is limited to specialized centers. IVH represents a therapeutic challenge for neurosurgeons, neurologists, and intensivists. Thus, a better understanding of this dramatic event will help in better tailoring the treatment strategies.

Keywords

Intraventricular Cerebral hemorrhage Fibrinolytic agents Ventriculostomy Neuroendoscopy 

Notes

Acknowledgments

The authors thank Miss Apollonia Annang for her assistance in English corrections and Keven Ponte for his computing assistance.

Sources of funding

None.

Conflicts of interest/disclosures

The authors declare that they have no conflict of interest or financial disclosure.

References

  1. 1.
    Almairac F, Litrico S, Fontaine D, Lonjon M, Paquis P (2011) Evaluation of intraventricular thrombolysis for severe intraventricular hemorrhage after aneurysmal rupture: a prospective randomized study. Paper presented at the 4th World ICH conference 2011, World Federation of Neurosurgical Societies and European Associations of Neurosurgery, Newcastle, UK, 3 May 2011Google Scholar
  2. 2.
    Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN et al (2011) American Heart Association. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40:994–1025 (review)CrossRefGoogle Scholar
  3. 3.
    Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD (2006) Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the stitch trial. Acta Neurochir Suppl 96:65–68Google Scholar
  4. 4.
    Chen CC, Liu CL, Tung YN, Lee HC, Chuang HC, Lin SZ et al (2011) Endoscopic surgery for intraventricular hemorrhage (IVH) caused by thalamic hemorrhage: comparisons of endoscopic surgery and external ventricular drainage (EVD) surgery. World Neurosurg 75:264–268PubMedCrossRefGoogle Scholar
  5. 5.
    Chen Z, Gao C, Hua Y, Keep RF, Muraszko K, Xi G (2011) Role of iron in brain injury after intraventricular hemorrhage. Stroke 42:465–470PubMedCrossRefGoogle Scholar
  6. 6.
    Cheung RTF, Zou LY (2003) Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 34:1717–1722Google Scholar
  7. 7.
    Daverat P, Castel JP, Dartigues JF, Orgogozo JM (1991) Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis. Stroke 22:1–6Google Scholar
  8. 8.
    Diringer MN, Edwards DF, Zazulia AR (1998) Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 29:1352–1357PubMedCrossRefGoogle Scholar
  9. 9.
    Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, Narula R, Guo KH et al (2010) Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage. Neurosurgery 66:648–655PubMedCrossRefGoogle Scholar
  10. 10.
    Findlay JM, Jacka MJ (2004) Cohort study of intraventricular thrombolysis with recombinant tissus plasminogen activator for aneurysmal intraventricular hemorrhage. Neurosurgery 55:532–537PubMedCrossRefGoogle Scholar
  11. 11.
    Flint AC, Roebken A, Singh V (2008) Primary intraventricular hemorrhage: yield of diagnostic angiography and clinical outcome. Neurocrit Care 8:330–336PubMedCrossRefGoogle Scholar
  12. 12.
    Franke CL, van Swieten JC, Algra A, van Gijn J (1992) Prognostic factors in patients with intracerebral haematoma. J Neurol Neurosurg Psychiatry 55:653–657PubMedCrossRefGoogle Scholar
  13. 13.
    Gaberel T, Magheru C, Parienti JJ, Huttner HB, Vivien D, Emery E (2011) Intraventricular fibrinolysis versus external ventricular drainage alone in intraventricular hemorrhage: a meta-analysis. Stroke 42:2776–2781PubMedCrossRefGoogle Scholar
  14. 14.
    Gaberel T, Emery E, Vivien D (2011) Letter by Gaberel et al. regarding article, “Dose effect of intraventricular fibrinolysis in ventricular hemorrhage”. Stroke 42:e548–e549 (letter)PubMedCrossRefGoogle Scholar
  15. 15.
    Graeb DA, Robertson WD, Lapointe JS, Nugent RA, Harrison PB (1982) Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis. Radiology 143:91–96PubMedGoogle Scholar
  16. 16.
    Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM et al (2008) Intraventricular hemorrhage. Anatomic relationships and clinical implications. Neurology 70:848–852Google Scholar
  17. 17.
    Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC (2001) The ich score: a simple reliable grading scale for intracerebral hemorrhage. Stroke 32:891–897Google Scholar
  18. 18.
    Hinson HE, Melnychuk E, Muschelli J, Hanley DF, Awad IA, Ziai WC (2012) Drainage efficiency with dual versus single catheters in severe intraventricular hemorrhage. Neurocrit Care 16:399–405PubMedCrossRefGoogle Scholar
  19. 19.
    Komatsu F, Komatsu M, Wakuta N, Oshiro S, Tsugu H, Iwaasa M et al (2010) Comparison of clinical outcomes of intraventricular hematoma between neuroendoscopic removal and extraventricular drainage. Neurol Med Chir (Tokyo) 50:972–976CrossRefGoogle Scholar
  20. 20.
    LaPointe M, Haines S (2002) Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003692. doi: 10.1002/14651858.CD003692
  21. 21.
    Liberatore GT, Samson A, Bladin C, Schleuning WD, Medcalf RL (2003) Vampire bat salivary plasminogen activator (Desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 34:537–543PubMedCrossRefGoogle Scholar
  22. 22.
    Little JR, Blomquist GA Jr, Ethier R (1977) Intraventricular hemorrhage in adults. Surg Neurol 8:143–149PubMedGoogle Scholar
  23. 23.
    Lodhia KR, Shakui P, Keep RF (2006) Hydrocephalus in a rat model of intraventricular hemorrhage. Acta Neurochir Suppl 96:207–211PubMedCrossRefGoogle Scholar
  24. 24.
    Longatti PL, Martinuzzi A, Fiorindi A, Maistrello L, Carteri A (2004) Neuroendoscopic management of intraventricular hemorrhage. Stroke 35:e35–e38PubMedCrossRefGoogle Scholar
  25. 25.
    Longatti P, Fiorindi A, Di Paola F, Curtolo S, Basaldella L, Martinuzzi A (2006) Coiling and neuroendoscopy: a new perspective in the treatment of intraventricular haemorrhages due to bleeding aneurysms. J Neurol Neurosurg Psychiatry 77:1354–1358PubMedCrossRefGoogle Scholar
  26. 26.
    Marti Fabregas J, Belvis R, Guardia E, Cocho D, Munoz J, Marruecos L et al (2003) Neurology 61:1051–1056Google Scholar
  27. 27.
    Masè G, Zorzon M, Biasutti E, Tasca G, Vitrani B, Cazzato G (1995) Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival. Acta Neurol Scand 91:306–309PubMedCrossRefGoogle Scholar
  28. 28.
    Mayfrank L, Kissler J, Raoofi R, Delsing P, Weis J, Küker W et al (1997) Ventricular dilatation in experimental intraventricular hemorrhage in pigs. Characterization of cerebrospinal fluid dynamics and the effects of fibrinolytic treatment. Stroke 28:141–148PubMedCrossRefGoogle Scholar
  29. 29.
    Mohr G, Ferguson G, Khan M, Malloy D, Watts R, Benoit B et al (1983) Intraventricular hemorrhage from ruptured aneurysm. J Neurosurg 58:482–487PubMedCrossRefGoogle Scholar
  30. 30.
    Morgan T, Awad I, Keyl P, Lane K, Hanley D (2008) Preliminary report of the clot lysis evaluating accelerated resolution of intraventricular hemorrhage (CLEAR-IVH) clinical trial. Acta Neurochir Suppl 105:217–220PubMedCrossRefGoogle Scholar
  31. 31.
    Morgenstern LB, Hemphill JC 3rd, Anderson C, Becker K, Broderick JP, Connolly ES Jr, The American Heart Association Stroke Council and Council on Cardiovascular Nursing et al (2010) Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 41:2108–2129PubMedCrossRefGoogle Scholar
  32. 32.
    Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA (2011) Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke 42:3009–3016PubMedCrossRefGoogle Scholar
  33. 33.
    Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET et al (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7:59–64PubMedCrossRefGoogle Scholar
  34. 34.
    Nieuwkamp DJ, de Gans K, Rinkel GJ, Algra A (2000) Treatment and outcome of severe intraventricular extension in patients with subarachnoid or intracerebral hemorrhage: a systematic review of the literature. J Neurol 247:117–121 (review)PubMedCrossRefGoogle Scholar
  35. 35.
    Nishikawa T, Ueba T, Kajiwara M, Miyamatsu N, Yamashita K (2009) A priority treatment of the intraventricular hemorrhage (IVH) should be performed in the patients suffering intracerebral hemorrhage with large IVH. Clin Neurol Neurosurg 111:450–453Google Scholar
  36. 36.
    Nomura S, Ishihara H, Yoneda H, Shirao S, Shinoyama M, Suzuki M (2010) Neuroendoscopic evacuation of intraventricular hematoma associated with thalamic hemorrhage to shorten the duration of external ventricular drainage. Surg Neurol Int 1:43–49PubMedCrossRefGoogle Scholar
  37. 37.
    Oertel JM, Mondorf Y, Baldauf J, Schroeder HW, Gaab MR (2009) Endoscopic third ventriculostomy for obstructive hydrocephalus due to intracranial hemorrhage with intraventricular extension. J Neurosurg 111:1119–1126PubMedCrossRefGoogle Scholar
  38. 38.
    Ozdemir O, Calisaneller T, Hasturk A, Aydemir F, Caner H, Altinors N (2008) Prognostic significance of third ventricle dilation in spontaneous intracerebral hemorrhage: a preliminary clinical study. Neurol Res 30:406–410PubMedCrossRefGoogle Scholar
  39. 39.
    Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: part 1. Canine intraventricular blood cast model. Neurosurgery 19:540–546PubMedCrossRefGoogle Scholar
  40. 40.
    Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: part 2. In vivo safety study of intraventricular urokinase. Neurosurgery 19:547–552PubMedCrossRefGoogle Scholar
  41. 41.
    Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular blood clot with urokinase in a canine model: part 3. Effect of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus. Neurosurgery 19:553–572PubMedCrossRefGoogle Scholar
  42. 42.
    Qureshi AI, Safdar K, Weil J (1995) Predictors of early deterioration and mortality in Black Americans with spontaneous intracerebral hemorrhage. Stroke 26:1764–1767PubMedCrossRefGoogle Scholar
  43. 43.
    Ramakrishna R, Sekhar LN, Ramanathan D, Temkin N, Hallam D, Ghodke BV et al (2010) Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage. Neurosurgery 67:110–117PubMedCrossRefGoogle Scholar
  44. 44.
    Razzaq AA, Hussain R (1998) Determinants of 30-day mortality of spontaneous intracerebral hemorrhage in Pakistan. Surg Neurol 50:336–343Google Scholar
  45. 45.
    Ritschl E, Auer LM (1987) Endoscopic evacuation of an intracerebral and intraventricular haemorrhage. Arch Dis Child 62:1163–1181PubMedCrossRefGoogle Scholar
  46. 46.
    Rohde V, Rohde I, Thiex R, Ince A, Jung A, Dückers G et al (2002) Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 97:954–962PubMedCrossRefGoogle Scholar
  47. 47.
    Shapiro AS, Campbell RL, Scully T (1994) Hemorrhagic dilation of the fourth ventricle: an ominous predictor. J Neurosurg 80:805–809PubMedCrossRefGoogle Scholar
  48. 48.
    Shen PH, Matsuoka Y, Kawajiri K, Kanai M, Hoda K, Yamamoto S et al (1990) Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir (Tokyo) 30:329–333CrossRefGoogle Scholar
  49. 49.
    Staykov D, Huttner HB, Struffert T, Ganslandt O, Doerfler A, Schwab S et al (2009) Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 40:3275–3280PubMedCrossRefGoogle Scholar
  50. 50.
    Staykov D, Huttner HB, Lunkenheimer J, Volbers B, Struffert T, Doerfler A et al (2010) Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage. J Neurol Neurosurg Psychiatry 81:105–108PubMedCrossRefGoogle Scholar
  51. 51.
    Staykov D, Volbers B, Wagner I, Huttner HB, Doerfler A, Schwab S et al (2011) Prognostic significance of third ventricle blood volume in intracerebral haemorrhage with severe ventricular involvement. J Neurol Neurosurg Psychiatry 82:1260–1263PubMedCrossRefGoogle Scholar
  52. 52.
    Staykov D, Wagner I, Volbers B, Huttner HB, Doerfler A, Schwab S et al (2011) Dose effect of intraventricular fibrinolysis in ventricular hemorrhage. Stroke 42:2061–2064PubMedCrossRefGoogle Scholar
  53. 53.
    Takahashi O, Cook EF, Nakamura T, Saito J, Ikawa F, Fukui T (2006) Risk stratification for in-hospital mortality in spontaneous intracerebral hemorrhage: a classification and regression tree analysis. Q J Med 99: 743–750Google Scholar
  54. 54.
    Torres A, Plans G, Martino J, Godino O, Garcia I, Gracia B et al (2008) Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment. Br J Neurosurg 22:269–274PubMedCrossRefGoogle Scholar
  55. 55.
    Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543–552PubMedGoogle Scholar
  56. 56.
    Tuhrim S, Horowitz DR, Sacher M, Godbold JH (1999) Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27:617–621PubMedCrossRefGoogle Scholar
  57. 57.
    Varelas N, Rickert KL, Cusick J (2005) Intraventricular hemorrhage after aneurysmal subarachnoid hemorrhage: pilot study of treatment with intraventricular tissue plasminogen activator. Neurosurgery 56:205–213PubMedCrossRefGoogle Scholar
  58. 58.
    Wang YC, Lin CW, Shen CC, Lai SC, Kuo JS (2002) Tissue plasminogen activator for the treatment of intraventricular hematoma: the dose–effect relationship. J Neurol Sci 202:35–41PubMedCrossRefGoogle Scholar
  59. 59.
    Xi G, Keep RF, Hoff JT (2006) Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol 5:53–63PubMedCrossRefGoogle Scholar
  60. 60.
    Yadav YR, Mukerji G, Shenoy R, Basoor A, Jain G, Nelson A (2007) Endoscopic management of hypertensive intraventricular haemorrhage with obstructive hydrocephalus. BMC Neurol 7:1–9PubMedCrossRefGoogle Scholar
  61. 61.
    Yepes M, Roussel BD, Ali C, Vivien D (2008) Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 32:48–55PubMedCrossRefGoogle Scholar
  62. 62.
    Zhang Z, Li X, Liu Y, Shao Y, Xu S, Yang Y (2007) Application of neuroendoscopy in the treatment of intraventricular hemorrhage. Cerebrovasc Dis 24:91–96PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Thomas Gaberel
    • 1
    • 2
  • Christian Magheru
    • 1
  • Evelyne Emery
    • 1
    • 2
  1. 1.Department of NeurosurgeryCaen University HospitalCaenFrance
  2. 2.INSERM, U919, Sérine Protease and Pathophysiology of the Neurovascular Unit, SP2U, UMR CNRS 6232, Centre d’Imagerie et de Neurosciences Appliquées aux Pathologies GIP CyceronUniversity Caen Lower NormandyCaenFrance

Personalised recommendations